GAO Report Spotlights SARS-CoV-2 Vaccine Development

Government Accountability Office: Science & Tech Spotlight: COVID-19 Vaccine Development
This GAO report discusses the vaccine development process, highlighting opportunities, challenges, and policy questions for the development of a novel coronavirus vaccine. The report notes that the U.S. is funding multiple efforts to develop vaccines for SARS-CoV-2, the virus that causes COVID-19 (5/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.